Fangsheng Pharmaceuticals: The controlling shareholder pledges 8.75 million shares, and the overall pledge risk is manageable.

Fangsheng Pharmaceutical announced that on February 11, the controlling shareholder and actual controller Zhang Qinghua completed the pledge of 8.75 million shares for the purpose of replacing expiring financing. As of the disclosure date of the announcement, Zhang Qinghua directly holds 156 million shares, accounting for 35.53% of the total share capital, with a cumulative pledge of 64.0752 million shares, accounting for 41.07% of his direct holdings and 14.59% of the total share capital. Zhang Qinghua and his concerted action parties collectively hold 166 million shares, with a cumulative pledge of 64.0752 million shares, accounting for 38.70% of the total shareholdings. The overall pledge risk is controllable, there is no risk of forced liquidation, and this pledge will not have any significant adverse impact on the company's operation or governance.